Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Memantine in Patients With Chronic Glaucoma [Phase 3]
Phase 3 clinical trial update evaluating memantine for open-angle glaucoma (chronic glaucoma) sponsored by Allergan.
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Memantine in Patients With Chronic Glaucoma [Phase 3]
A Phase 3 trial evaluating memantine in patients with open-angle glaucoma has completed; the study status is reported as completed.
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial assessing patient satisfaction with Timolol in adults with open-angle glaucoma or ocular hypertension; results have been poste…
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
This clinical trial update reports results from a comfort survey in patients with open-angle glaucoma or ocular hypertension who were treate…
-
FDA approval · 2010-08-31FDA Approved: LUMIGAN — Original Application (Allergan, Inc.)
The FDA approved Lumigan (bimatoprost) from Allergan, Inc. as an original application for lowering intraocular pressure in adults with open-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-08-31FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost filed by Mylan Pharmaceuticals, approving a generic version of latanoprost for l…
-
FDA approval · 2010-08-13FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) from Allergan, Inc., likely involving labeling changes or …
-
FDA approval · 2010-08-03FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc., representing a regulatory update to the product.
-
FDA approval · 2010-07-29FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost submitted by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: Phacotrabeculotomy Versus CCI+Phaco in Patients With Borderline Control of Intraocular Pressure [NA]
A terminated clinical trial comparing phacotrabeculotomy versus CCI+phaco for patients with border-line control of intraocular pressure in p…
-
FDA approval · 2010-06-18FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
FDA approved a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) from Thea Pharma Inc., indicating approva…
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Safety and Efficacy of a Glaucoma Drug Delivery System [Phase 2]
Phase 2 clinical trial assessing the safety and effectiveness of a glaucoma drug delivery system completed, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-04-12Clinical Trial Update: A Long-term Safety Study of Once-daily Travatan [Phase 3]
Long-term safety results from a Phase 3 study evaluating once-daily Travatan (latanoprost) in open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS research · 2010-03-11Clinical Trial Update: Efficacy Comparison of Xalatan and Azopt on POAG and OH [NA]
A clinical trial update comparing Xalatan (latanoprost) and Azopt (brinzolamide) for primary open-angle glaucoma and ocular hypertension, wi…
-
CLINICAL_TRIALS trial_result · 2010-02-12Clinical Trial Update: Equivalence Study of Dorzolamide 2% Eye Drops Solution [Phase 3]
Phase 3 equivalence study evaluating dorzolamide 2% eye drops has been completed.
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
Phase 4 trial comparing single-dose comfort of Travatan Z in one eye to Xalatan in the other eye in patients with open-angle glaucoma or ocu…
-
CLINICAL_TRIALS trial_result · 2010-02-01Clinical Trial Update: Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) [Phase 4]
Phase 4 trial evaluating Cosopt (dorzolamide/timolol) over 8 weeks in patients with open-angle glaucoma or ocular hypertension has completed…
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: SOLX Titanium Sapphire Laser for Trabeculoplasty [Phase 3]
A Phase 3 trial evaluating the SOLX Titanium Sapphire Laser for trabeculoplasty in open-angle glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension [Phase 4]
A Phase 4 trial comparing Travatan (travoprost) with Timoptic (timolol) for open-angle glaucoma or ocular hypertension has completed and pos…
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma? [NA]
A completed clinical trial investigates whether polymorphisms in MMP1, MMP3, and MMP9 are genetic risk factors for primary open-angle glauco…
-
CLINICAL_TRIALS trial_result · 2010-01-08Clinical Trial Update: Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 4]
A Phase 4 study of Travatan (travoprost) and Cosopt (dorzolamide/timolol) for primary open-angle glaucoma or ocular hypertension was termina…
-
FDA approval · 2009-11-18FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Sandoz Inc)
The FDA approved a generic dorzolamide hydrochloride and timolol maleate ophthalmic solution from Sandoz for lowering intraocular pressure i…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Glaucoma [Phase 2, Phase 3]
A phase 2/3 trial comparing dorzolamide versus timolol on optic disc blood flow in open-angle glaucoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-01Clinical Trial Update: Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)
This clinical trial update documents the collection of blood specimens from patients in AL-3789 studies addressing elevated intraocular pres…
-
CLINICAL_TRIALS research · 2009-10-01Clinical Trial Update: Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy [EARLY_Phase 1]
This is an early-phase clinical trial update evaluating near-infrared light neuroprotection for glaucomatous optic neuropathy. The study is …